Device / Technology News

RSS

Collaborative Research Discovers New Treatments for Alzheimer' Disease

A new multimillion-dollar project will bring together researchers from the Indiana University School of Medicine and the IU Luddy School of Informatics, Computing, and Engineering as they work to solve one of medical science's greatest needs: Identifying new treatments for Alzheimer's disease and related dementias.

16 Jun 2026

AI Decodes Biomolecular Condensates to Revolutionize Drug Discovery

Researchers at Princeton University have harnessed AI to understand how drugs affect the dynamics of vital structures within the cell.

13 Jun 2026

Scientists Track Tiny Human Proteins Using Novel Laser Phase Plate

In a landmark achievement in biological imaging, researchers at the University of California, Berkeley and Biohub today announced the successful demonstration of the laser phase plate.

12 Jun 2026

AI Reducing Animal Testing, Speeding Drug Trials

Brisbane biotech company Gelomics is helping advance a new generation of drug development through its platform for creating lab-grown human tissue models, giving researchers a more human-relevant way to test compounds in early-stage research without relying on animal experiments.

11 Jun 2026

Computational Tool Enhances Reliability of DNA Nano-Vehicles for Medicine

Scaffolded DNA and RNA origami is a technology that enables scientists to create tiny, very precise two and three-dimensional objects.

10 Jun 2026

Building A Soft Robotic Heart That Mimics HFpEF Progression

Researchers developed a soft robotic heart model that replicates HFpEF, enhancing understanding of the disease and supporting innovative treatment strategies.

10 Jun 2026

DNA Barcode Technology Enables Massive Simultaneous Drug Candidate Validation

A Korean research team has launched a public drug discovery service capable of screening and validating tens of millions of compounds simultaneously.

10 Jun 2026

Label-Free Raman Spectroscopy Accelerates Precision Phage Therapy

This study was led by Prof. Jian Xu (Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences) in collaboration with Prof. Hongzhou Lu (Shenzhen Third People's Hospital) and Prof. Jiadong Huang (University of Jinan).

8 Jun 2026

Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated workflow for the characterization of charge and size variants in bispecific antibodies and biosimilars.

From Bio-Techne 4 Jun 2026

Study Shows How AI and Single Cell Science are Changing Modern Medicine

Recent technological advances have pushed the boundaries of cellular biology far beyond what was conceivable even decades ago

4 Jun 2026

Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally

Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling.

From Evosep 3 Jun 2026

Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development

Evosep announces the launch of Evosep Proteomics, an ecosystem designed to standardize and scale LC-MS-based proteomics for research and pharmaceutical drug development.

From Evosep 2 Jun 2026

NeuroSense Tracks Brain Fluid in Real Time to Prevent Deadly Infections

A research team led by the University of Waterloo has created a new monitoring system to save lives and significantly reduce health-care costs in brain-injury cases through the early detection of infections in intensive care units.

2 Jun 2026

Identifying a Genetic Switch That Halts Human Nerve Regeneration

Researchers at Cambridge have created tiny circuits in the lab that replicate the connections between the brain and spinal cord, which control human movements.

29 May 2026

M2care and ZEISS Ventures Support Maculaser Oy to Advance Pioneering Temperature-Controlled Retinal Laser Therapy

Maculaser Oy, a Finland-based medtech company developing a first-of-its-kind temperature-controlled retinal laser therapy, announces a new undisclosed investment with the participation of M2care, a European healthtech venture studio, and ZEISS Ventures, the corporate venture capital arm of the ZEISS Group.

29 May 2026

Cornell Researchers Develop Safer CRISPR Technique Using DNA Nicks

Researchers at Cornell University have developed a safer and more precise way to study how genes function in living tissues by refining a recently developed CRISPR-based genetic technique in fruit flies, enabling researchers to better study how genes contribute to development and disease.

28 May 2026